Maxi Investments CY Ltd boosted its stake in shares of MKS Inc. (NASDAQ:MKSI – Free Report) by 130.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,510 shares of the scientific and technical instruments company’s stock after buying an additional 2,553 shares during the quarter. Maxi Investments CY Ltd’s holdings in MKS were worth $1,197,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Keating Financial Advisory Services Inc. purchased a new position in shares of MKS during the second quarter worth approximately $25,000. Allied Private Wealth LLC bought a new stake in shares of MKS during the second quarter valued at approximately $33,000. Clearstead Trust LLC purchased a new stake in shares of MKS in the second quarter valued at approximately $36,000. Ancora Advisors LLC purchased a new stake in shares of MKS in the second quarter valued at approximately $36,000. Finally, Carolina Wealth Advisors LLC boosted its holdings in shares of MKS by 47.5% in the second quarter. Carolina Wealth Advisors LLC now owns 87 shares of the scientific and technical instruments company’s stock valued at $39,000 after purchasing an additional 28 shares during the period. Institutional investors own 99.79% of the company’s stock.
MKS Stock Performance
Shares of MKS stock opened at $202.28 on Tuesday. The company has a market capitalization of $13.68 billion, a PE ratio of 32.26, a P/E/G ratio of 0.41 and a beta of 2.03. The company has a 50-day simple moving average of $254.77 and a two-hundred day simple moving average of $276.63. MKS Inc. has a one year low of $134.74 and a one year high of $447.62. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.72 and a current ratio of 1.14.
MKS (NASDAQ:MKSI – Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $3.30 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.39. MKS had a net margin of 10.15% and a return on equity of 24.72%. The business had revenue of $1.25 billion for the quarter, compared to analysts’ expectations of $1.20 billion. During the same period last year, the business earned $1.77 EPS. The company’s revenue was up 28.3% compared to the same quarter last year. MKS has set its Q3 2026 guidance at 3.270-3.890 EPS. Research analysts expect that MKS Inc. will post 13.13 EPS for the current fiscal year.
MKS Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Tuesday, August 25th were given a dividend of $0.25 per share. The ex-dividend date of this dividend was Tuesday, August 25th. This represents a $1.00 dividend on an annualized basis and a yield of 0.5%. MKS’s dividend payout ratio is presently 15.95%.
Analyst Ratings Changes
Several research analysts recently issued reports on the company. Cantor Fitzgerald reissued an “overweight” rating and issued a $600.00 price objective on shares of MKS in a research note on Monday, August 3rd. Wall Street Zen raised MKS from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 8th. BMO Capital Markets initiated coverage on MKS in a report on Tuesday, June 30th. They issued an “outperform” rating and a $453.00 target price for the company. Mizuho lowered their target price on MKS from $360.00 to $330.00 and set an “outperform” rating for the company in a report on Tuesday, August 25th. Finally, Morgan Stanley dropped their price target on MKS from $345.00 to $330.00 and set an “overweight” rating on the stock in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $374.86.
Check Out Our Latest Analysis on MKS
Insider Buying and Selling at MKS
In other MKS news, Director Elizabeth Mora sold 300 shares of the firm’s stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $250.96, for a total value of $75,288.00. Following the completion of the sale, the director directly owned 18,845 shares in the company, valued at $4,729,341.20. This trade represents a 1.57% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Tseng-Chung Lee sold 10,000 shares of MKS stock in a transaction on Friday, August 14th. The stock was sold at an average price of $302.01, for a total transaction of $3,020,100.00. Following the completion of the transaction, the chief executive officer directly owned 134,776 shares in the company, valued at $40,703,699.76. This represents a 6.91% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 10,757 shares of company stock worth $3,227,146 over the last three months. Corporate insiders own 0.57% of the company’s stock.
MKS Profile
MKS Instruments, Inc (NASDAQ: MKSI) develops technologies that enable precision control and measurement in manufacturing and research environments. The company provides instruments, components, systems and process-control solutions used to measure and control pressure, flow, vacuum, gas delivery, temperature and other critical production conditions.
Its product portfolio includes vacuum solutions, pressure and flow-control instruments, gas and vapor delivery systems, plasma and reactive-gas technologies, power delivery systems, process-monitoring equipment, analytical instruments and materials-characterization tools.
Recommended Stories
- Five stocks we like better than MKS
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for MKS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS and related companies with MarketBeat.com's FREE daily email newsletter.
